Sodium bicarbonate in preventing contrast nephropathy in patients at risk for volume overload : a randomized controlled trial
BACKGROUND: Sodium bicarbonate has been recently proposed as a prophylactic measure for the prevention of contrast-induced nephropathy (CIN). We aimed to compare the efficacy of the combination of sodium bicarbonate with half saline, and half saline alone in preventing CIN in patients having uncontrolled hypertension, compensated severe heart failure or a history of pulmonary edema.
METHODS: Seventy-two patients undergoing elective coronary angiography with a serum creatinine level > or =1.5 mg/dL who had uncontrolled hypertension, compensated severe heart failure or a history of pulmonary edema were prospectively enrolled in a single-center, double-blind, randomized, controlled trial from August 2007 to July 2008 and were assigned to either an infusion of sodium bicarbonate plus half saline (n=36) or half saline alone (n=36). The primary end point was an absolute (> or =0.5 mg/dL) or relative (> or =25%) increase in serum creatinine 48 hours after the procedure (CIN).
RESULTS: There were no significant differences between the groups regarding their baseline demographic and biochemical characteristics, as well as the underlying disease. A total of 6.1% of the patients receiving sodium bicarbonate plus half saline developed CIN as opposed to 6.3% of the patients in the half saline group, which was not statistically different (odds ratio = 0.97; 95% confidence interval, 0.13-7.3; p=1.0).
CONCLUSION: The combination therapy of sodium bicarbonate plus half saline does not offer additional benefits over hydration with half saline alone in the prevention of CIN.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2010 |
|---|---|
| Erschienen: |
2010 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Journal of nephrology - 23(2010), 2 vom: 01. März, Seite 216-23 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vasheghani-Farahani, Ali [VerfasserIn] |
|---|
| Anmerkungen: |
Date Completed 06.05.2010 Date Revised 16.12.2020 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM195280245 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM195280245 | ||
| 003 | DE-627 | ||
| 005 | 20231223202443.0 | ||
| 007 | tu | ||
| 008 | 231223s2010 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0651.xml |
| 035 | |a (DE-627)NLM195280245 | ||
| 035 | |a (NLM)20175053 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Vasheghani-Farahani, Ali |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sodium bicarbonate in preventing contrast nephropathy in patients at risk for volume overload |b a randomized controlled trial |
| 264 | 1 | |c 2010 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 06.05.2010 | ||
| 500 | |a Date Revised 16.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Sodium bicarbonate has been recently proposed as a prophylactic measure for the prevention of contrast-induced nephropathy (CIN). We aimed to compare the efficacy of the combination of sodium bicarbonate with half saline, and half saline alone in preventing CIN in patients having uncontrolled hypertension, compensated severe heart failure or a history of pulmonary edema | ||
| 520 | |a METHODS: Seventy-two patients undergoing elective coronary angiography with a serum creatinine level > or =1.5 mg/dL who had uncontrolled hypertension, compensated severe heart failure or a history of pulmonary edema were prospectively enrolled in a single-center, double-blind, randomized, controlled trial from August 2007 to July 2008 and were assigned to either an infusion of sodium bicarbonate plus half saline (n=36) or half saline alone (n=36). The primary end point was an absolute (> or =0.5 mg/dL) or relative (> or =25%) increase in serum creatinine 48 hours after the procedure (CIN) | ||
| 520 | |a RESULTS: There were no significant differences between the groups regarding their baseline demographic and biochemical characteristics, as well as the underlying disease. A total of 6.1% of the patients receiving sodium bicarbonate plus half saline developed CIN as opposed to 6.3% of the patients in the half saline group, which was not statistically different (odds ratio = 0.97; 95% confidence interval, 0.13-7.3; p=1.0) | ||
| 520 | |a CONCLUSION: The combination therapy of sodium bicarbonate plus half saline does not offer additional benefits over hydration with half saline alone in the prevention of CIN | ||
| 650 | 4 | |a Comparative Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Contrast Media |2 NLM | |
| 650 | 7 | |a Hypotonic Solutions |2 NLM | |
| 650 | 7 | |a Sodium Chloride |2 NLM | |
| 650 | 7 | |a 451W47IQ8X |2 NLM | |
| 650 | 7 | |a Sodium Bicarbonate |2 NLM | |
| 650 | 7 | |a 8MDF5V39QO |2 NLM | |
| 650 | 7 | |a Creatinine |2 NLM | |
| 650 | 7 | |a AYI8EX34EU |2 NLM | |
| 700 | 1 | |a Sadigh, Gelareh |e verfasserin |4 aut | |
| 700 | 1 | |a Kassaian, Seyed Ebrahim |e verfasserin |4 aut | |
| 700 | 1 | |a Khatami, Seyed Mohammad Reza |e verfasserin |4 aut | |
| 700 | 1 | |a Fotouhi, Akbar |e verfasserin |4 aut | |
| 700 | 1 | |a Razavi, Seyed Amirhossein |e verfasserin |4 aut | |
| 700 | 1 | |a Mansournia, Mohammad Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Kazemisaeid, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Soleimani, Abbas |e verfasserin |4 aut | |
| 700 | 1 | |a Pourhosseini, Hamid Reza |e verfasserin |4 aut | |
| 700 | 1 | |a Alidoosti, Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Hajizeinali, Ali Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Hoseini, Kianoush |e verfasserin |4 aut | |
| 700 | 1 | |a Nematipour, Ebrahim |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of nephrology |d 1995 |g 23(2010), 2 vom: 01. März, Seite 216-23 |w (DE-627)NLM08977650X |x 1724-6059 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2010 |g number:2 |g day:01 |g month:03 |g pages:216-23 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2010 |e 2 |b 01 |c 03 |h 216-23 | ||